8-KShareholder Matters

CME GROUP INC. 8-K Report, Shareholder Vote Results (May 13, 2024)

Filed May 13, 2024For Securities:CME

Summary

CME Group Inc. (CME) filed an 8-K on May 13, 2024, detailing the outcomes of its 2024 Annual Meeting of Shareholders held on May 9, 2024. The report indicates strong shareholder support for the election of seventeen Equity Directors and the ratification of Ernst & Young LLP as the independent auditor. Additionally, a majority of shareholders provided an advisory "say-on-pay" vote, approving the compensation of named executive officers. A significant point of note is the failure to achieve a quorum for the election of Class B Directors across several categories (B-1, B-2, and B-3). As a result, the existing directors in these classes will continue to serve as "holdovers" under Delaware law and the company's bylaws until their successors are duly elected at the 2025 Annual Meeting or their earlier departure.

Key Highlights

  • 1Shareholders overwhelmingly re-elected all seventeen Equity Directors to serve until 2025.
  • 2The appointment of Ernst & Young LLP as the independent public accounting firm for 2024 was ratified with strong shareholder approval.
  • 3The advisory vote on executive compensation ('say-on-pay') was approved by a majority of shareholders.
  • 4A quorum was not achieved for the election of Class B-1 Directors, resulting in the "holdover" status for William W. Hobert, Patrick J. Mulchrone, and Robert J. Tierney Jr.
  • 5A quorum was not achieved for the election of Class B-2 Directors, resulting in the "holdover" status for Michael G. Dennis and Patrick W. Maloney.
  • 6A quorum was not achieved for the election of a Class B-3 Director, resulting in the "holdover" status for Elizabeth A. Cook.
  • 7Approximately 87.34% of the issued and outstanding Class A and B common stock was represented at the meeting, indicating robust shareholder participation.

Frequently Asked Questions

The primary outcomes include the re-election of seventeen Equity Directors, ratification of Ernst & Young LLP as the independent auditor, and approval of executive compensation through an advisory vote. However, a key development was the failure to achieve a quorum for the election of several Class B Directors, leading to their continued service as 'holdovers'.

The 'holdover' status for the elected Class B Directors (in categories B-1, B-2, and B-3) occurred because a quorum was not achieved for those specific director elections. Under Delaware law and CME's bylaws, these directors will continue to serve until their successors are elected at the next annual meeting or until they resign or are removed.

The 'holdover' status means that while the directors continue their duties, it highlights a governance issue related to securing sufficient shareholder participation or votes for these specific board positions. The company will need to address this at the 2025 annual meeting to elect successors or ensure a quorum is met.

Shareholders provided an advisory 'say-on-pay' vote, and the compensation of the Company's named executive officers was approved with 253,068,323 votes for, 37,272,265 votes against, and 362,707 abstentions.